Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $193B |
| FY2017, ended Dec 31, 2017 | $216B |
| FY2018, ended Dec 31, 2018 | $242B |
| FY2019, ended Dec 31, 2019 | $217B |
| FY2020, ended Dec 31, 2020 | $205B |
| FY2021, ended Dec 31, 2021 | $332B |
| FY2022, ended Dec 31, 2022 | $288B |
| FY2023, ended Dec 31, 2023 | $163B |
| FY2024, ended Dec 31, 2024 | $150B |
| FY2025, ended Dec 31, 2025 | $142B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $138B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.8B |
| FY2017, ended Dec 31, 2017 | $52.5B |
| FY2018, ended Dec 31, 2018 | $40.8B |
| FY2019, ended Dec 31, 2019 | $40.9B |
| FY2020, ended Dec 31, 2020 | $41.7B |
| FY2021, ended Dec 31, 2021 | $81.3B |
| FY2022, ended Dec 31, 2022 | $101B |
| FY2023, ended Dec 31, 2023 | $59.6B |
| FY2024, ended Dec 31, 2024 | $63.6B |
| FY2025, ended Dec 31, 2025 | $62.6B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $63.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.21B | $14.4B |
| FY2017, ended Dec 31, 2017 | $21.3B | $14.8B |
| FY2018, ended Dec 31, 2018 | $11.2B | $13.8B |
| FY2019, ended Dec 31, 2019 | $16.0B | $10.5B |
| FY2020, ended Dec 31, 2020 | $9.16B | $12.2B |
| FY2021, ended Dec 31, 2021 | $22.0B | $29.9B |
| FY2022, ended Dec 31, 2022 | $31.4B | $26.0B |
| FY2023, ended Dec 31, 2023 | $2.12B | $4.79B |
| FY2024, ended Dec 31, 2024 | $8.03B | $9.84B |
| FY2025, ended Dec 31, 2025 | $7.77B | $9.07B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $4.33B | $11.0B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.60B |
| FY2017, ended Dec 31, 2017 | $1.34B |
| FY2018, ended Dec 31, 2018 | $1.14B |
| FY2019, ended Dec 31, 2019 | $1.12B |
| FY2020, ended Dec 31, 2020 | $1.79B |
| FY2021, ended Dec 31, 2021 | $1.94B |
| FY2022, ended Dec 31, 2022 | $416M |
| FY2023, ended Dec 31, 2023 | $2.85B |
| FY2024, ended Dec 31, 2024 | $1.04B |
| FY2025, ended Dec 31, 2025 | $1.14B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $976M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $37.2B |
| FY2017, ended Dec 31, 2017 | $43.5B |
| FY2018, ended Dec 31, 2018 | $41.7B |
| FY2019, ended Dec 31, 2019 | $52.1B |
| FY2020, ended Dec 31, 2020 | $4.56B |
| FY2021, ended Dec 31, 2021 | $38.4B |
| FY2022, ended Dec 31, 2022 | $35.8B |
| FY2023, ended Dec 31, 2023 | $71.9B |
| FY2024, ended Dec 31, 2024 | $64.4B |
| FY2025, ended Dec 31, 2025 | $64.8B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | $63.2B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 4.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 5.95B |
| FY2017, ended Dec 31, 2017 | 5.95B |
| FY2018, ended Dec 31, 2018 | 5.55B |
| FY2019, ended Dec 31, 2019 | 5.55B |
| FY2020, ended Dec 31, 2020 | 5.58B |
| FY2021, ended Dec 31, 2021 | 5.62B |
| FY2022, ended Dec 31, 2022 | 5.62B |
| FY2023, ended Dec 31, 2023 | 5.65B |
| FY2024, ended Dec 31, 2024 | 5.67B |
| FY2025, ended Dec 31, 2025 | 5.69B |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | 5.70B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.00B | $691M |
| FY2017, ended Dec 31, 2017 | $5.00B | $840M |
| FY2018, ended Dec 31, 2018 | $12.2B | $923M |
| FY2019, ended Dec 31, 2019 | $8.87B | $687M |
| FY2020, ended Dec 31, 2020 | $0 | $755M |
| FY2021, ended Dec 31, 2021 | $0 | $1.18B |
| FY2022, ended Dec 31, 2022 | $2.00B | $872M |
| FY2023, ended Dec 31, 2023 | $0 | $525M |
| FY2024, ended Dec 31, 2024 | $0 | $877M |
| FY2025, ended Dec 31, 2025 | — | $799M |
| Trailing 12 months to Jun 28, 2026 (through Q2 FY2026) | — | $947M |
Valuation
At current price- Market Cap
- $170B
- P/E
- 39.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.7×
- Price / Book
- 2.0×
- EV / EBITDA
- 17.2×
Growth
Trailing 12 months- Revenue (TTM)
- $63.7B
- Revenue Growth YoY
- −0.2%
- Revenue CAGR 3Y
- −14.8%
- Revenue CAGR 5Y
- 8.5%
- EPS Growth YoY
- −59.8%
- Net Income Growth YoY
- −59.7%
Profitability
Trailing 12 months- Gross Margin
- 73.2%
- Operating Margin
- —
- Net Margin
- 6.8%
- FCF Margin
- 17.2%
- Return on Equity
- 5.0%
Earnings
Trailing 12 months- Net Income
- $4.33B
- EPS (diluted)
- $0.76
- EBITDA
- $13.5B
- Operating Income
- —
Balance Sheet
As of Jun 28, 2026- Cash and cash equivalents
- $976M
- Total Debt
- $63.2B
- Net Debt
- $62.2B
- Total Assets
- $201B
- Total Liabilities
- $116B
- Shareholders' Equity
- $85.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $13.4B
- Capital Expenditure
- $2.42B
- Free Cash Flow
- $11.0B
Dividends and risk
Last 12 months- Dividend Yield
- 5.8%
- Dividend / Share
- $1.72
- Beta (5Y)
- 0.32
Every ratio is calculated from the company’s reported figures.